AI-Driven Thermal Imaging
Real-time visualization of cancerous tissue without contrast agents.
Non-Invasive & Cost-Effective
No radiation exposure or expensive iMRI setup.
Seamless OR Integration
Works within existing surgical workflows without special equipment requirements
Faster Decision-Making
Reduces surgery time and improves resection precision.
TECHNOLOGY READINESS LEVEL
LumiScan has successfully demonstrated its thermal imaging concept in controlled lab settings.
Ongoing prototype development and AI algorithm refinement for clinical validation.
Preparing for bench testing and pre-clinical evaluation in 2026
HOW HE WILL DRIVE LUMISCAN’S SUCCESS:
Technology Leadership
Will guide the engineering team in AI algorithm integration, device optimization, and medical-grade sensor development.
Commercial Strategy
Will drive LumiScan’s go-to-market plan, leveraging his experience launching technical products in regulated environments.
Global Scale-Up
With previous experience managing export strategies, will steer LumiScan toward North American and European expansion
Current Surgical Challenges
Surgeons rely on pre-operative imaging, which does not provide real-time feedback.
Intraoperative imaging methods are costly, invasive, and require contrast agents.
Residual cancer cells significantly contribute to cancer recurrence
Meet the Experts
Tayebeh Barzang
Chief Financial Officer
Arka Kamali
Chief Technology Officer
Marjan Vakili
Chief Executive Officer
Afshin Shojaei
Chief Operating Officer
Seyedmojtaba Hosseini
Chief Trade & Commercial
Strategy Officer